Brain Computer Interfaces (BCI)

Overview

What It Is A brain-computer interface (BCI) is a system that measures brain activity and translates it into commands that control a computer, communication device, robotic limb, or other external technology—or, in some designs, that stimulate the brain to restore sensation or function. BCIs are used mainly when severe paralysis, ALS, locked-in syndrome, or similar conditions limit the ability to move or speak. They range from research tools and clinical-trial implants to emerging non-invasive headsets.

How It Works Sensors detect neural signals (from the scalp, the brain surface, or inside cortex). Software decodes patterns linked to intention—for example, thinking about moving a cursor or selecting letters. The decoded signal drives an output (typing, robotic arm, wheelchair, speech prosthesis). With practice, users learn to produce clearer signals, and algorithms adapt—an interplay of machine learning and experience-dependent plasticity. Some systems also write information back into the brain (stimulation) to restore touch or vision.

Types used today

1. Non-invasive BCIs - Record from outside the head (usually EEG on the scalp; sometimes fNIRS or other sensors). - No surgery; easier to start, lower risk, but signals are weaker and less precise. - Examples: research and consumer EEG headsets (e.g., systems in the OpenBCI / EMOTIV family and clinical EEG-BCI setups); experimental non-invasive approaches using ultrasound or other modalities under development. - Typical uses today: communication spelling systems, attention/neurofeedback research, early assistive control in clinic or lab settings.

2. Minimally invasive / endovascular BCIs - Reach the brain through blood vessels rather than opening the skull (e.g., a stent-like electrode placed in a vessel over motor cortex). - Examples: Synchron Stentrode — implanted via the jugular vein; tested in people with ALS and severe paralysis for computer control and communication.

3. Invasive (implanted) BCIs - Electrodes placed on the brain surface (ECoG) or into cortex (intracortical arrays) for higher-resolution signals. - Examples: - Blackrock Neurotech / BrainGate-class Utah arrays — long-running research implants for paralysis and communication - Neuralink N1 — high-channel intracortical implant in active clinical trials for quadriplegia and ALS - Precision Neuroscience Layer 7 — surface arrays aimed at high-resolution recording with a less penetrating design - Paradromics and other high-bandwidth systems in early clinical stages - Typical goals: cursor and device control, typing, robotic arm use, speech decoding, and future sensory feedback.

Getting access and clinical trials Most advanced BCIs are available only through clinical trials or specialized research programs—not as routine clinic products. Practical steps: - Search ClinicalTrials.gov for “brain-computer interface,” “BCI,” “BrainGate,” “Neuralink,” “Synchron,” or “motor cortex implant,” filtered by recruiting status and location. - Ask a neurologist, physiatrist, or ALS/spinal-cord clinic about trial referrals. - Major trial activity has been concentrated at selected U.S. and international academic and industry sites (e.g., programs linked to BrainGate consortium sites, Synchron COMMAND trial sites, Neuralink PRIME sites, and related centers). Eligibility usually requires specific diagnoses (e.g., severe paralysis, ALS), preserved cognition, and ability to consent and attend follow-up.

Where the technology is headed - Higher channel counts and more stable long-term implants - Better speech and handwriting decoding from neural activity - Wireless, fully implanted systems with less external hardware - Pairing BCI control with rehabilitation to support recovery, not only substitution - Expanded sensory feedback (touch, vision) and broader indications beyond paralysis - Gradual movement from pure research toward regulated clinical products (timelines still measured in years for most systems)

Where to look for leading-edge applications - Academic consortia such as BrainGate and partner hospitals - Industry trial programs: Neuralink, Synchron, Blackrock Neurotech, Precision Neuroscience, Paradromics, and related companies - Specialized ALS, spinal-cord injury, and locked-in care centers that collaborate on BCI studies - ClinicalTrials.gov and hospital research coordinators for current recruiting studies

On-label / regulatory status - Almost all high-performance BCIs remain investigational (clinical trials / research use only). - A small number of related components or narrower systems may have limited clearances; routine commercial “prescription BCI” for paralysis is not yet standard care in most places. - Non-invasive EEG-based tools are more accessible but are generally assistive/research-grade rather than approved disease-modifying treatments.

Conditions - Primary focus today: severe paralysis (e.g., after spinal cord injury or brainstem stroke), ALS / locked-in syndrome, and related communication or motor restoration needs - Research interest also includes epilepsy monitoring, stroke rehabilitation support, and sensory restoration (e.g., investigational vision programs) - Note: Almost all high-performance systems remain investigational; non-invasive tools are more accessible but typically less precise.

How it is administered

Non-invasive: headset or cap with sensors in clinic, lab, or home research settings. Minimally invasive / invasive: surgical or endovascular implantation at specialized trial centers, followed by calibration, training, and ongoing technical support. Access is usually through clinical trials rather than standard care.

Conditions connected in the NPA database

The NPA Treatment Database lists this treatment in connection with 3 condition records. A database relationship does not establish effectiveness, safety, or suitability for an individual.

• Stroke
• Traumatic Brain Injury (TBI)
• Epilepsy

Related questions

These controlled question pages reference this treatment through stored condition relationships.

• What treatments are listed for Epilepsy in the NPA database?
• What treatments are listed for Stroke in the NPA database?
• What treatments are listed for Traumatic Brain Injury (TBI) in the NPA database?

Symptoms connected in the NPA database

The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.

Practical information

Results and outcomes described in the source record

Learning to use a BCI typically takes days to weeks of training after setup or implant; performance can continue to improve with practice. Trial timelines span months to years of follow-up.

Side effects and risks

Non-invasive: very low risk (skin irritation, fatigue). Invasive: surgical risks (infection, bleeding, device failure), possible seizures or neurological change, and long-term explant/revision considerations. Trial teams provide detailed risk counseling.

Research context in the NPA database

Research summary

Evidence Level: Emerging to Moderate (stronger for research demonstrations than for routine clinical products) What the research shows: Multiple groups have shown that people with severe paralysis can control cursors, type, operate robotic arms, or generate speech-related output with implanted BCIs. Non-invasive systems support simpler communication and control with lower risk. Large-scale commercial availability is still limited. Key takeaway: BCIs are a rapidly advancing option for communication and control when movement or speech is severely limited; most advanced systems are reached through clinical trials at specialized centers.

Research detail

Overview Brain-computer interfaces translate neural activity into device control or communication. They include non-invasive headsets, endovascular implants, and fully invasive cortical arrays, with the highest performance systems still largely in clinical trials.

Evidence Base and Published Work • Decades of BrainGate and related intracortical research demonstrate cursor control, typing, and robotic arm use in people with paralysis. • Synchron’s endovascular Stentrode trials report safety and computer-control feasibility without open-brain surgery. • Neuralink and other companies are running active trials expanding patient numbers and applications (including speech-related goals). • Non-invasive EEG-BCI literature supports assistive communication with more modest bit rates. • Regulatory status is mostly investigational; a few components or related systems have achieved narrower clearances.

Outcomes Outcomes most frequently described in trials include reliable cursor and click control, typing or communication rates sufficient for daily interaction, and, in advanced setups, robotic limb or speech-prosthesis control. Results depend on implant type, signal quality, algorithm, and user training.

Questions to ask a provider

1. Is a BCI appropriate for my level of paralysis or communication impairment, and would I likely need a non-invasive system or a clinical-trial implant? 2. How do I find and enroll in a relevant clinical trial (ClinicalTrials.gov, ALS/SCI clinic referral, specific company trials)? 3. What daily function could I realistically control (cursor, typing, robotic arm, speech output), and how much training is required? 4. What are the surgical vs non-surgical risks for the systems I might qualify for? 5. Which centers or consortia (e.g., BrainGate-linked sites, Synchron, Neuralink trial sites) are currently enrolling patients like me?